Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Mechanisms of Resistance

Comparative Study of Genotype and Virulence in CTX-M-Producing and Non-Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae Isolates

Juyoun Shin, Kwan Soo Ko
Juyoun Shin
Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon, South Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kwan Soo Ko
Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon, South Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AAC.02499-13
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Molecular and virulence characteristics of CTX-M-producing and non-extended-spectrum-β-lactamase (non-ESBL)-producing Klebsiella pneumoniae isolates were compared. Lack of shared characteristics between the two groups suggested that most CTX-M-producing K. pneumoniae isolates in South Korea did not occur by transfer of blaCTX-M into susceptible strains. Conjugation assays confirmed that the plasmid with the blaCTX-M-15 gene confers virulence as well as antimicrobial resistance, suggesting that a CTX-M-15-producing clone such as ST11 may have a selective advantage even without antibiotic pressure.

TEXT

In parallel with the use of antibiotic drugs, the prevalence of Escherichia coli and Klebsiella pneumoniae strains producing CTX-M-type extended-spectrum β-lactamases (ESBLs) has increased worldwide (1). In addition to CTX-M-15-producing E. coli, CTX-M-15 has increased in prevalence in K. pneumoniae worldwide (2–4). In K. pneumoniae, blaCTX-M-15 is carried mainly by IncFII-type plasmids (5). Production of the SHV-type ESBLs in K. pneumoniae is associated with an increased tendency to invade epithelial cells and expression of fimbrial adhesions (6). Although highly virulent clones expressing CTX-M-type β-lactamase, such as E. coli ST131, have been reported (7), the association of CTX-M enzyme production with virulence and fitness in K. pneumoniae is not clear. In this study, we compared genotypic and phenotypic characteristics between CTX-M-producing and non-ESBL-producing K. pneumoniae isolates from South Korea. In addition, the fitness cost of carrying the blaCTX-M-15 gene-bearing plasmid was investigated.

In this study, 98 K. pneumoniae isolates, which were collected from patients with bacteremia from nine South Korean hospitals as a part of multicenter surveillance study from September to December 2008, were included (8). Thirty-three isolates were found to express blaCTX-M genes (18 blaCTX-M-14 and 15 blaCTX-M-15), while 65 isolates did not produce any ESBL. ESBL activity was confirmed using the double-disc method. In vitro antimicrobial susceptibility testing was performed by a broth microdilution method, according to the CLSI guidelines (9). Multilocus sequence typing (MLST) was performed as described previously (http://www.pasteur.fr/recherche/genopole/PF8/mlst/Kpneumoniae.html) with some modifications. Pulsed-field gel electrophoresis (PFGE) was performed for all ST11 K. pneumoniae isolates (10). PCR assays were performed to monitor for the presence of genes previously found to be associated with virulence in K. pneumoniae (11, 12). The string test was used to determine the hypermucoviscosity phenotype (13). α-Hemolysin production was detected using a 5% sheep blood agar plate (14).

The transfer of the plasmid carrying blaCTX-M-15 was accomplished using an E. coli DH5α strain as described previously (15). The plasmid carrying the blaCTX-M-15 gene from an ST11 K. pneumoniae isolate, K01-12226, was used (5). The plasmid carrying blaCTX-M-15 was transferred into five non-ESBL-producing ST11 K. pneumoniae isolates, K01-1054, K01-6053, K01-7096, K01-8102, and K01-8139, from E. coli DH5α as a donor (8). The presence of blaCTX-M-15 in transconjugants was confirmed by PCR. A serum sensitivity assay was performed on clinical isolates and transconjugants, as previously described (16). Fisher's exact test was used to determine the significance of differences in serum resistance between strains using SPSS version 11.5 (SPSS, Chicago, IL, USA).

The CTX-M-producing K. pneumoniae isolates showed significantly greater resistance to most antibiotics except ampicillin, amikacin, and imipenem than did non-ESBL-producing isolates (P < 0.05) (Table 1). While cf29a, a gene in E. coli encoding adhesin CS31A and associated with diarrhea in humans, was found in only one CTX-M-14-producing, ST11 isolate, it was present in 14 non-ESBL-producing isolates (P = 0.018) (Table 1). Eight (72.7%) of 11 non-ESBL-producing ST11 isolates possessed the cf29a gene, and four ST163 isolates tested positive for it. In addition to cf29a, allS, which encodes an activator of the allantoin regulon, was found more frequently in non-ESBL-producing isolates (P = 0.05).

View this table:
  • View inline
  • View popup
TABLE 1

Antimicrobial resistance and virulence factors of CTX-M-producing and non-ESBL-producing K. pneumoniae isolates

In MLST analysis, a total of 52 different STs were identified among the 98 K. pneumoniae isolates: 19 STs among the 33 CTX-M-producing isolates and 36 among the 65 non-ESBL-producing isolates (Table 2). Only three STs (ST11, ST15, and ST48) were detected in both CTX-M-producing and non-ESBL-producing isolates. This suggests that most CTX-M-producing K. pneumoniae isolates in South Korea did not occur by transfer of the blaCTX-M gene into susceptible strains. In PFGE analysis, 16 ST11 isolates did not show exactly the same restriction pattern, but similarities in pattern could be identified. In particular, an approximately 388-kb fragment was found only in CTX-M-15-producing K. pneumoniae isolates. It was revealed to be a plasmid carrying blaCTX-M-15, by PCR. In addition, PFGE analysis of transconjugants receiving a plasmid showed an additional 388-kb band (not shown). It may be premature to conclude that CTX-M-15-producing ST11 isolates arise by transfer of a blaCTX-M-15-bearing plasmid into susceptible strains unique to South Korea, since ST11 is distributed among CTX-M-15-producing clones worldwide (17).

View this table:
  • View inline
  • View popup
TABLE 2

MLST analysis of CTX-M-producing and non-ESBL-producing K. pneumoniae isolates

Non-ESBL-producing K. pneumoniae isolates showed higher serum resistance than did CTX-M-producing isolates (P = 0.004) (Fig. 1A). In addition, the hypermucoviscosity phenotype was more frequently identified in non-ESBL-producing isolates; only three CTX-M-producing isolates (9.1%) expressed the hypermucoviscosity phenotype compared to 19 non-ESBL-producing isolates (29.2%) (P = 0.038). None of the K. pneumoniae isolates produced α-hemolysin.

FIG 1
  • Open in new tab
  • Download powerpoint
FIG 1

Results of serum resistance assay are shown here as CFU viability. Error bars indicate standard deviations. (A) Serum resistance assay for all CTX-M-producing and non-ESBL-producing K. pneumoniae isolates. Significance is shown for the difference between CTX-M-producing and non-ESBL-producing K. pneumoniae isolates (*, P < 0.05). (B) Survival rate of each non-ESBL-producing K. pneumoniae isolate and its transconjugant after incubation for 2 h.

To understand the effects of the plasmid on fitness measures such as growth rate and serum resistance, plasmids carrying the blaCTX-M-15 gene of an ST11 isolate were transferred to non-ESBL-producing ST11 isolates by conjugation. All of these transconjugants showed substantial increases in MICs for cephalosporins, with one exception (cefotaxime for T-6053). The CTX-M-producing, non-ESBL-producing, and transconjugant strains showed no significant differences in growth rates. Although serum resistance did not differ between CTX-M-producing and non-ESBL-producing ST11 K. pneumoniae isolates, transconjugants showed higher survival rates against serum than did their host isolates and donors (Fig. 1B). Comparing the survival rates against serum in pairs of transconjugant and host isolates, transconjugants showed significantly higher serum resistance than did their host isolates, except for the pair that included K01-1054 and T-1054. The traT gene in the plasmid may contribute to serum resistance, which explains the increased survival rates against serum in the transconjugants.

As a whole, non-ESBL-producing K. pneumoniae isolates were assumed to be more virulent than CTX-M-producing isolates. First of all, non-ESBL-producing isolates showed a higher rate of resistance against human serum than did CTX-M-producing K. pneumoniae isolates. Second, the hypermucoviscosity phenotype was more frequently found in non-ESBL-producing isolates. In addition, while CTX-M-producing isolates contained 7.64 virulence factors on average, 8.54 virulence factors, on average, were identified in non-ESBL-producing isolates (P = 0.005).

However, serum resistance did not differ between CTX-M-15-producing and non-ESBL-producing isolates of ST11. More importantly, four out of five transconjugants showed higher serum resistance than did their hosts (Fig. 1B). This suggests that plasmids with the blaCTX-M-15 gene may confer virulence as well as antimicrobial resistance, although only one kind of plasmid (IncFII) was tested in this study. Thus, CTX-M-15-producing K. pneumoniae isolates may carry more than one positively selective trait, implying that antimicrobial-resistant strains could increase in prevalence even without antimicrobial pressure. Although increased serum resistance is generally associated with decreased virulence and fitness, credible evidence to the contrary has emerged (18). Global dissemination of highly pathogenic and resistant clones would be cause for great concern (7).

ACKNOWLEDGMENTS

The K. pneumoniae strains used in this study were obtained from the Asian Bacterial Bank (ABB) of the Asia Pacific Foundation for Infectious Diseases (APFID; Seoul, South Korea).

This research was supported by the Basic Science Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Science, ICT and Future Planning (2010-0004848). J. Shin was supported partly by the Basic Science Research Program through the NRF funded by the Ministry of Education (2013R1A1A2062884).

FOOTNOTES

    • Received 15 November 2013.
    • Returned for modification 24 November 2013.
    • Accepted 28 January 2014.
    • Accepted manuscript posted online 10 February 2014.
  • Copyright © 2014, American Society for Microbiology. All Rights Reserved.

REFERENCES

  1. 1.↵
    1. Canton R,
    2. Coque TM
    . 2006. The CTX-M β-lactamase pandemic. Curr. Opin. Microbiol. 9:466–475. doi:10.1016/j.mib.2006.08.011.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    1. Coelho A,
    2. González-López JJ,
    3. Miró E,
    4. Alonso-Tarrés C,
    5. Mirelis B,
    6. Larrosa MN,
    7. Bartolomé RM,
    8. Andreu A,
    9. Navarro F,
    10. Johnson JR,
    11. Prats G
    . 2010. Characterization of the CTX-M-15-encoding gene in Klebsiella pneumoniae strains from the Barcelona metropolitan area: plasmid diversity and chromosomal integration. Int. J. Antimicrob. Agents 36:73–78. doi:10.1016/j.ijantimicag.2010.03.005.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Ensor VM,
    2. Jamal W,
    3. Rotimi VO,
    4. Evans JT,
    5. Hawkey PM
    . 2009. Predominance of CTXM-15 extended-spectrum β-lactamases in diverse Escherichia coli and Klebsiella pneumoniae from hospital and community patients in Kuwait. Int. J. Antimicrob. Agents 33:487–489. doi:10.1016/j.ijantimicag.2008.10.011.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Ko KS,
    2. Lee JY,
    3. Baek JY,
    4. Suh JY,
    5. Lee MY,
    6. Choi JY,
    7. Yeom JS,
    8. Kim YS,
    9. Jung SI,
    10. Shin SY,
    11. Heo ST,
    12. Kwon KT,
    13. Son JS,
    14. Kim SW,
    15. Chang HH,
    16. Ki HK,
    17. Chung DR,
    18. Peck KR,
    19. Song JH
    . 2010. Predominance of an ST11 extended-spectrum β-lactamase-producing Klebsiella pneumoniae clone causing bacteraemia and urinary tract infections in Korea. J. Med. Microbiol. 59:822–828. doi:10.1099/jmm.0.018119-0.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Shin J,
    2. Choi MJ,
    3. Ko KS
    . 2012. Replicon sequence typing of IncF plasmids and the genetic environments of blaCTX-M-15 indicate multiple acquisitions of blaCTX-M-15 in Escherichia coli and Klebsiella pneumoniae isolates from South Korea. J. Antimicrob. Chemother. 67:1853–1857. doi:10.1093/jac/dks143.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Sahly H,
    2. Navon-Venezia S,
    3. Roesler L,
    4. Hay A,
    5. Carmeli Y,
    6. Podschun R,
    7. Hennequin C,
    8. Forestier C,
    9. Ofek I
    . 2008. Extended-spectrum β-lactamase production is associated with an increase in cell invasion and expression of fimbrial adhesions in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 52:3029–3034. doi:10.1128/AAC.00010-08.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Woodford N,
    2. Turton JF,
    3. Livermore DM
    . 2011. Multiresistant Gram-negative bacteria: the role of high-risk clones for dissemination of antibiotic resistance. FEMS Microbiol. Lett. 35:736–755. doi:10.1111/j.1574-6976.2011.00268.x.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    1. Shin J,
    2. Kim DH,
    3. Ko KS
    . 2011. Comparison of CTX-M-14- and CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae isolates from patients with bacteremia. J. Infect. 63:39–47. doi:10.1016/j.jinf.2011.05.003.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    Clinical and Laboratory Standards Institute. 2011. Performance standards for antimicrobial susceptibility testing. 21st informational supplement. Document M100-S21. Clinical and Laboratory Standards Institute, Wayne, PA.
  10. 10.↵
    1. Samuelsen O,
    2. Naseer U,
    3. Tofteland S,
    4. Skutlaberg DH,
    5. Onken A,
    6. Hjetland R,
    7. Sundsfjord A,
    8. Giske CG
    . 2009. Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden. J. Antimicrob. Chemother. 63:654–658. doi:10.1093/jac/dkp018.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Brisse S,
    2. Fevre C,
    3. Passet V,
    4. Issenhuth-Jeanjean S,
    5. Tournebize R,
    6. Diancourt L,
    7. Grimont P
    . 2009. Virulent clones of Klebsiella pneumoniae: identification and evolutionary scenario based on genomic and phenotypic characterization. PLoS One 4:e4982. doi:10.1371/journal.pone.0004982.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Hennequin C,
    2. Forestier C
    . 2009. oxyR, a LysR-type regulator involved in Klebsiella pneumoniae mucosal and abiotic colonization. Infect. Immun. 77:5449–5457. doi:10.1128/IAI.00837-09.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Wiskur BJ,
    2. Hunt JJ,
    3. Callegan MC
    . 2008. Hypermucoviscosity as a virulence factor in experimental Klebsiella pneumoniae endophthalmitis. Invest. Ophthalmol. Vis. Sci. 49:4931–4938. doi:10.1167/iovs.08-2276.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Koczura R,
    2. Kaznowski A
    . 2003. Occurrence of the Yersinia high-pathogenicity island and iron uptake systems in clinical isolates of Klebsiella pneumoniae. Microb. Pathog. 35:197–202. doi:10.1016/S0882-4010(03)00125-6.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    1. Wollheim C,
    2. Guerra IMF,
    3. Conte VD,
    4. Hoffman SP,
    5. Schreiner FJ,
    6. Delamare AP,
    7. Barth AL,
    8. Echeverrigaray S,
    9. Costa SO
    . 2011. Nosocomial and community infections due to class A extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella spp. in southern Brazil. Braz. J. Infect. Dis. 15:138–143. doi:10.1590/S1413-86702011000200008.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Dozois CM,
    2. Fairbrother JM,
    3. Harel J,
    4. Bosse M
    . 1992. pap- and pil-related DNA sequences and other virulence determinants associated with Escherichia coli isolated from septicemic chickens and turkeys. Infect. Immun. 60:2648–2656.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Damjanova I,
    2. Tóth A,
    3. Pászti J,
    4. Hajbel-Vékony G,
    5. Jakab M,
    6. Berta J,
    7. Milch H,
    8. Füzi M
    . 2008. Expansion and countrywide dissemination of ST11, ST15, and ST147 ciprofloxacin-resistant CTX-M-15-type β-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005—the new ‘MRSAs'? J. Antimicrob. Chemother. 62:978–985. doi:10.1093/jac/dkn287.
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    1. Beceiro A,
    2. Tamás M,
    3. Bou G
    . 2013. Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world? Clin. Microbiol. Rev. 26:185–230. doi:10.1128/CMR.00059-12.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
Download PDF
Citation Tools
Comparative Study of Genotype and Virulence in CTX-M-Producing and Non-Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae Isolates
Juyoun Shin, Kwan Soo Ko
Antimicrobial Agents and Chemotherapy Mar 2014, 58 (4) 2463-2467; DOI: 10.1128/AAC.02499-13

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Comparative Study of Genotype and Virulence in CTX-M-Producing and Non-Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae Isolates
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Comparative Study of Genotype and Virulence in CTX-M-Producing and Non-Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae Isolates
Juyoun Shin, Kwan Soo Ko
Antimicrobial Agents and Chemotherapy Mar 2014, 58 (4) 2463-2467; DOI: 10.1128/AAC.02499-13
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • TEXT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596